These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 28386481)

  • 1. iPS cell technologies and their prospect for bone regeneration and disease modeling: A mini review.
    Csobonyeiova M; Polak S; Zamborsky R; Danisovic L
    J Adv Res; 2017 Jul; 8(4):321-327. PubMed ID: 28386481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induced pluripotent stem cells as a new strategy for cardiac regeneration and disease modeling.
    Iglesias-García O; Pelacho B; Prósper F
    J Mol Cell Cardiol; 2013 Sep; 62():43-50. PubMed ID: 23643470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pluripotent Stem Cells for Gene Therapy of Degenerative Muscle Diseases.
    Loperfido M; Steele-Stallard HB; Tedesco FS; VandenDriessche T
    Curr Gene Ther; 2015; 15(4):364-80. PubMed ID: 26122099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Advances in Therapeutic Applications of Induced Pluripotent Stem Cells.
    Rami F; Beni SN; Kahnamooi MM; Rahimmanesh I; Salehi AR; Salehi R
    Cell Reprogram; 2017 Apr; 19(2):65-74. PubMed ID: 28266864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induced pluripotent stem cells in regenerative medicine and disease modeling.
    Walmsley GG; Hyun J; McArdle A; Senarath-Yapa K; Hu MS; Chung MT; Wong VW; Longaker MT; Wan DC
    Curr Stem Cell Res Ther; 2014 Mar; 9(2):73-81. PubMed ID: 24359141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stem cell treatment for musculoskeletal disease.
    Carstairs A; Genever P
    Curr Opin Pharmacol; 2014 Jun; 16():1-6. PubMed ID: 24561638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are induced pluripotent stem cells the future of cell-based regenerative therapies for spinal cord injury?
    Salewski RP; Eftekharpour E; Fehlings MG
    J Cell Physiol; 2010 Mar; 222(3):515-21. PubMed ID: 20020443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal stem cells in regenerative medicine: Focus on articular cartilage and intervertebral disc regeneration.
    Richardson SM; Kalamegam G; Pushparaj PN; Matta C; Memic A; Khademhosseini A; Mobasheri R; Poletti FL; Hoyland JA; Mobasheri A
    Methods; 2016 Apr; 99():69-80. PubMed ID: 26384579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling human neurological disorders with induced pluripotent stem cells.
    Imaizumi Y; Okano H
    J Neurochem; 2014 May; 129(3):388-99. PubMed ID: 24286589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel cell sources for bone regeneration.
    Li C; Mills Z; Zheng Z
    MedComm (2020); 2021 Jun; 2(2):145-174. PubMed ID: 34766140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using Human Induced Pluripotent Stem Cells to Model Skeletal Diseases.
    Barruet E; Hsiao EC
    Methods Mol Biol; 2016; 1353():101-18. PubMed ID: 25549831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intra-discal injection of autologous, hypoxic cultured bone marrow-derived mesenchymal stem cells in five patients with chronic lower back pain: a long-term safety and feasibility study.
    Elabd C; Centeno CJ; Schultz JR; Lutz G; Ichim T; Silva FJ
    J Transl Med; 2016 Sep; 14(1):253. PubMed ID: 27585696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential application of induced pluripotent stem cells in cell replacement therapy for Parkinson's disease.
    Chen LW; Kuang F; Wei LC; Ding YX; Yung KK; Chan YS
    CNS Neurol Disord Drug Targets; 2011 Jun; 10(4):449-58. PubMed ID: 21495962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone Marrow Concentrate (BMC) Therapy in Musculoskeletal Disorders: Evidence-Based Policy Position Statement of American Society of Interventional Pain Physicians (ASIPP).
    Manchikanti L; Centeno CJ; Atluri S; Albers SL; Shapiro S; Malanga GA; Abd-Elsayed A; Jerome M; Hirsch JA; Kaye AD; Aydin SM; Beall D; Buford D; Borg-Stein J; Buenaventura RM; Cabaret JA; Calodney AK; Candido KD; Cartier C; Latchaw R; Diwan S; Dodson E; Fausel Z; Fredericson M; Gharibo CG; Gupta M; Kaye AM; Knezevic NN; Kosanovic R; Lucas M; Manchikanti MV; Mason RA; Mautner K; Murala S; Navani A; Pampati V; Pastoriza S; Pasupuleti R; Philip C; Sanapati MR; Sand T; Shah RV; Soin A; Stemper I; Wargo BW; Hernigou P
    Pain Physician; 2020 Mar; 23(2):E85-E131. PubMed ID: 32214287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heart regeneration for clinical application update 2016: from induced pluripotent stem cells to direct cardiac reprogramming.
    Yamakawa H
    Inflamm Regen; 2016; 36():23. PubMed ID: 29259696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-human primate pluripotent stem cells for the preclinical testing of regenerative therapies.
    Rodriguez-Polo I; Behr R
    Neural Regen Res; 2022 Sep; 17(9):1867-1874. PubMed ID: 35142660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Regenerative medicine: applications and development in urology].
    Pinto F; Calarco A; Brescia A; Sacco E; D'Addessi A; Racioppi M; Bassi PF
    Urologia; 2007; 74(4):197-205. PubMed ID: 21086380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human cord blood applications in cell therapy: looking back and look ahead.
    Zhou H; Chang S; Rao M
    Expert Opin Biol Ther; 2012 Aug; 12(8):1059-66. PubMed ID: 22681655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies for heart regeneration: approaches ranging from induced pluripotent stem cells to direct cardiac reprogramming.
    Yamakawa H; Ieda M
    Int Heart J; 2015; 56(1):1-5. PubMed ID: 25742939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induced Pluripotent Stem Cells as a new Strategy for Osteogenesis and Bone Regeneration.
    Lou X
    Stem Cell Rev Rep; 2015 Aug; 11(4):645-51. PubMed ID: 26022504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.